ASBM Commends FDA for Approval, Clear Naming of First Biosimilar
March 9, 2015
ASBM Commends FDA for Approval, Clear Naming of First Biosimilar For Immediate Release: March 6, 2015 WASHINGTON – The Alliance for Safe Biologic Medicines today commended the U.S. Food and Drug Administration (FDA) on its approval of the first biosimilar to be available for sale in the U.S. market. Approval of Novartis’ Zarxio (filgrastim-sndz), […]